ATRA Atara Biotherapeutics Inc

For the fiscal year ended 31/12/2022: Atara Biotherapeutics Inc's revenues increased by 212.55% and amounted to 63.57M. Net income increased by 32.88% to -228.30M. Net assets decreased by 54.71% to 126.64M and EPS increased from -3.63 to -2.24.